$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000162828018009424 Filed on July 19, 2018

Income Statement

Concept	2018 Q2	2017 Q2	2017 Q1
Revenue	$3.752M	$4.310M	$4.306M
YoY Change	-12.96%	62.8%	89.26%
Cost Of Revenue	$1.950M	$2.639M	$2.698M
YoY Change	-26.11%	67.86%	81.96%
Gross Profit	$1.801M	$1.671M	$1.671M
YoY Change	7.82%	55.4%	110.75%
Gross Profit Margin	48.01%	38.76%	38.8%
Selling, General & Admin	$3.371M	$4.165M	$4.019M
YoY Change	-19.04%	0.97%	4.89%
% of Gross Profit	187.17%	249.28%	240.59%
Research & Development	$1.617M	$877.6K	$903.3K
YoY Change	84.24%	-22.19%	-21.91%
% of Gross Profit	89.76%	52.53%	54.07%
Depreciation & Amortization	$80.00K	$70.00K	$61.58K
YoY Change	14.29%	16.67%	-0.1%
% of Gross Profit	4.44%	4.19%	3.69%
Operating Expenses	$4.988M	$5.042M	$4.923M
YoY Change	-1.07%	-4.0%	-1.33%
Operating Profit	-$3.187M	-$3.372M	-$3.314M
YoY Change	-5.47%	-19.29%	-21.02%
Interest Expense		$130.0K	$80.00K
YoY Change		62.5%	-20.0%
% of Operating Profit
Other Income/Expense, Net	$10.00K
YoY Change
Pretax Income	$570.0K	-$3.240M	-$3.230M
YoY Change	-117.59%	-20.98%	-21.22%
Income Tax
% Of Pretax Income
Net Earnings	$573.9K	-$3.238M	-$3.232M
YoY Change	-117.73%	-20.94%	-21.07%
Net Earnings / Revenue	15.3%	-75.12%	-75.07%
Basic Earnings Per Share	$0.08	-$2.49	-$7.27
Diluted Earnings Per Share	$0.04	-$2.49	-$7.27
COMMON SHARES
Basic Shares Outstanding	7.330M shares	1.302M shares	1.001M shares
Diluted Shares Outstanding	13.92M shares	1.302M shares	1.001M shares

Balance Sheet

Concept	2018 Q2	2017 Q2	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.110M	$3.610M	$6.900M
YoY Change	96.95%	-68.14%	-21.05%
Cash & Equivalents	$7.109M	$3.612M	$6.897M
Short-Term Investments
Other Short-Term Assets	$690.0K	$1.720M	$1.420M
YoY Change	-59.88%	60.75%	97.22%
Inventory	$2.424M	$1.477M	$1.197M
Prepaid Expenses
Receivables	$1.114M	$984.5K	$950.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.34M	$7.794M	$10.46M
YoY Change	45.49%	-43.44%	-8.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$430.7K	$444.3K	$471.1K
YoY Change	-3.07%	-27.16%	-27.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$40.00K	$140.0K	$150.0K
YoY Change	-71.43%	-22.22%	-21.05%
Total Long-Term Assets	$468.8K	$588.9K	$625.5K
YoY Change	-20.39%	-26.39%	-26.41%
TOTAL ASSETS
Total Short-Term Assets	$11.34M	$7.794M	$10.46M
Total Long-Term Assets	$468.8K	$588.9K	$625.5K
Total Assets	$11.81M	$8.383M	$11.09M
YoY Change	40.86%	-42.51%	-9.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$799.8K	$758.2K	$404.1K
YoY Change	5.48%	18.47%	-70.72%
Accrued Expenses	$1.974M	$1.747M	$1.395M
YoY Change	13.03%	-5.59%	-25.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.087M	$3.670M	$3.065M
YoY Change	11.36%	26.1%	-6.26%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$40.00K	$170.0K
YoY Change		-63.64%	-10.53%
Total Long-Term Liabilities	$0.00	$40.00K	$170.0K
YoY Change	-100.0%	-63.64%	-10.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.087M	$3.670M	$3.065M
Total Long-Term Liabilities	$0.00	$40.00K	$170.0K
Total Liabilities	$4.087M	$3.711M	$3.237M
YoY Change	10.13%	23.09%	-6.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$189.3M	-$184.9M	-$181.7M
YoY Change	2.35%	7.68%
Common Stock	$736.00	$165.00	$874.00
YoY Change	346.06%	-66.46%	99.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.722M	$4.672M	$7.852M
YoY Change
Total Liabilities & Shareholders Equity	$11.81M	$8.383M	$11.09M
YoY Change	40.86%	-42.5%	-9.92%

Cashflow Statement

Concept	2018 Q2	2017 Q2	2017 Q1
OPERATING ACTIVITIES
Net Income	$573.9K	-$3.238M	-$3.232M
YoY Change	-117.73%	-20.94%	-21.07%
Depreciation, Depletion And Amortization	$80.00K	$70.00K	$61.58K
YoY Change	14.29%	16.67%	-0.1%
Cash From Operating Activities	$1.120M	-$3.260M	-$3.350M
YoY Change	-134.36%	-22.01%	-7.46%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$40.00K	$0.00
YoY Change	150.0%	33.33%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$100.0K	-$40.00K	$0.00
YoY Change	150.0%	33.33%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	10.00K	6.300M
YoY Change	-100.0%	-99.85%	-7975.0%
NET CHANGE
Cash From Operating Activities	1.120M	-3.260M	-3.350M
Cash From Investing Activities	-100.0K	-40.00K	0.000
Cash From Financing Activities	0.000	10.00K	6.300M
Net Change In Cash	1.020M	-3.290M	2.950M
YoY Change	-131.0%	-227.03%	-179.09%
FREE CASH FLOW
Cash From Operating Activities	$1.120M	-$3.260M	-$3.350M
Capital Expenditures	-$100.0K	-$40.00K	$0.00
Free Cash Flow	$1.220M	-$3.220M	-$3.350M
YoY Change	-137.89%	-22.41%	-8.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-93651	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7356731	shares
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1114496	USD
	us-gaap	Depreciation Depreciation	140989	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	196355142	USD
CY2017Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	127361	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197020869	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
	dei	Trading Symbol TradingSymbol	NURO
CY2017Q4	nuro	Accrued Compensation AccruedCompensation	786184	USD
CY2018Q2	nuro	Accrued Compensation AccruedCompensation	534467	USD
CY2017Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	666375	USD
CY2018Q2	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	1312618	USD
	nuro	Fair Value Adjustmentof Warrants Repricing FairValueAdjustmentofWarrantsRepricing	244611	USD
	nuro	Fair Value Adjustmentof Warrants Repricing FairValueAdjustmentofWarrantsRepricing	0	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-71388	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-645938	USD
CY2018Q2	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	294264	USD
CY2017Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2018Q2	nuro	Technology Fees TechnologyFees	450000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	733305	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	799785	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1049329	USD
CY2018Q2	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	189700	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2362124	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1974210	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	603000	USD
CY2018Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	320000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8826211	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7760047	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	925400	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	861153	shares
CY2017Q4	us-gaap	Assets Assets	9599224	USD
CY2018Q2	us-gaap	Assets Assets	11808220	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	9103374	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	11339424	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3949135	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3611949	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4043681	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7100000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7108915	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-337186	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3065234	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.12
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2706066	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7356731	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2706066	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7356731	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	271	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	736	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	2639402	USD
	us-gaap	Cost Of Revenue CostOfRevenue	5337004	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	1950304	USD
	us-gaap	Cost Of Revenue CostOfRevenue	4905564	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	820031	USD
CY2018Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
	us-gaap	Depreciation Depreciation	126254	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-9.12
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.49
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	298650	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M16D
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-208153	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1245347	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2667129	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1170634	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2974777	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	1670657	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	1670657	USD
	us-gaap	Gross Profit GrossProfit	3279177	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	1801264	USD
	us-gaap	Gross Profit GrossProfit	3788994	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	24160	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	66480	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	245786	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1288332	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	367295	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	31037	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-37869	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2019-01-15
CY2018Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6312378	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	225089	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281617	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	53464	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-609358	USD
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6584674	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6980585	shares
CY2017Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	133759	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	215617	USD
CY2018Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	11014	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	22279	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1637268	USD
CY2018Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	942780	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	2142561	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	2424178	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	505293	USD
CY2018Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1481398	USD
CY2017Q4	us-gaap	Liabilities Liabilities	4581835	USD
CY2018Q2	us-gaap	Liabilities Liabilities	4086613	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9599224	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11808220	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4581835	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4086613	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-130816	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6611695	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3196050	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-3237796	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6470196	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	573928	USD
	us-gaap	Net Income Loss NetIncomeLoss	1740180	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3237796	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10511878	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	573928	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1740180	USD
CY2017Q2	us-gaap	Noninterest Income NoninterestIncome	0	USD
	us-gaap	Noninterest Income NoninterestIncome	0	USD
CY2018Q2	us-gaap	Noninterest Income NoninterestIncome	3749999	USD
	us-gaap	Noninterest Income NoninterestIncome	8505704	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	5042212	USD
	us-gaap	Operating Expenses OperatingExpenses	9964990	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	4988349	USD
	us-gaap	Operating Expenses OperatingExpenses	10576797	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3371555	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6685813	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3187085	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6787803	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	234779	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	328722	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6839778	shares
CY2017Q2	us-gaap	Other Income OtherIncome	133759	USD
	us-gaap	Other Income OtherIncome	215617	USD
CY2018Q2	us-gaap	Other Income OtherIncome	3761013	USD
	us-gaap	Other Income OtherIncome	8527983	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37869	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130816	USD
CY2017Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4041682	USD
CY2018Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1867803	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	691835	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	55008	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	38127	USD
	us-gaap	Proceeds From Collaborators ProceedsFromCollaborators	8800000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6312378	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	160800	USD
CY2018Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	151321	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	440842	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	430669	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	877584	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1780868	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1616863	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2896427	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191338054	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-189300000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-189300016	USD
CY2017Q2	us-gaap	Revenues Revenues	4310059	USD
	us-gaap	Revenues Revenues	8616181	USD
CY2018Q2	us-gaap	Revenues Revenues	3751568	USD
	us-gaap	Revenues Revenues	8694558	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2919281	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5516993	USD
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2200852	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4705593	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	113635	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	371917	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5017389	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	7721607	USD
CY2017Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1302231	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1152441	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13915153	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13820363	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1302231	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1152441	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7330479	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-009424-index-headers.html	Edgar Link	pending
0001628280-18-009424-index.html	Edgar Link	pending
0001628280-18-009424.txt	Edgar Link	pending
0001628280-18-009424-xbrl.zip	Edgar Link	pending
a10q6302018document.htm	Edgar Link	pending
a10q6302018ex311.htm	Edgar Link	pending
a10q6302018ex312.htm	Edgar Link	pending
a10q6302018ex32.htm	Edgar Link	pending
a10q6302018leaseex1013.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
leasepg1.jpg	Edgar Link	pending
leasepg2.jpg	Edgar Link	pending
nuro-20180630.xml	Edgar Link	completed
nuro-20180630.xsd	Edgar Link	pending
nuro-20180630_cal.xml	Edgar Link	unprocessable
nuro-20180630_def.xml	Edgar Link	unprocessable
nuro-20180630_lab.xml	Edgar Link	unprocessable
nuro-20180630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2018 Q2 Form 10-Q Financial Statement

#000162828018009424 Filed on July 19, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2018 Q2 Form 10-Q Financial Statement

#000162828018009424 Filed on July 19, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro